• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素样生长因子I对葡萄糖、脂质和氨基酸代谢的多种作用。

Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism.

作者信息

Boulware S D, Tamborlane W V, Matthews L S, Sherwin R S

机构信息

Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06510.

出版信息

Am J Physiol. 1992 Jan;262(1 Pt 1):E130-3. doi: 10.1152/ajpendo.1992.262.1.E130.

DOI:10.1152/ajpendo.1992.262.1.E130
PMID:1733244
Abstract

The metabolic effects of recombinant human insulin-like growth factor I (rhIGF-I) on glucose, amino acid, and free fatty acid (FFA) metabolism were examined in nine healthy nonobese subjects. Each received a 3-h primed continuous infusion of rhIGF-I (20 micrograms/kg bolus, 0.4 microgram.kg-1.min-1) while maintaining euglycemia using an exogenous glucose infusion. Total IGF-I levels increased from 125 +/- 11 to 444 +/- 22 ng/ml, and free IGF-I levels rose from undetectable to 73 +/- 5 ng/ml. Insulin levels fell from 95 +/- 9 to 64 +/- 8 pM, and C-peptide fell from 453 +/- 48 to 206 +/- 29 pM; circulating glucagon levels also declined from 72 +/- 9 to 42 +/- 4 pg/ml, rhIGF-I produced a two- to threefold increase in glucose uptake as measured by [3H] glucose (from 10.3 +/- 0.6 to 27.4 +/- 3 mumol.kg-1.m-1), and, despite the fall in insulin secretion, there was a marked 60-70% inhibition of hepatic glucose production. Furthermore, FFA and branched-chain amino acids declined by 40-60% (411 +/- 58 to 165 +/- 36 and 406 +/- 23 to 219 +/- 14 microM, respectively). Our data demonstrate that rhIGF-I has potent effects on glucose (hepatic and peripheral), lipid, and amino acid metabolism in normal humans. The scope of the actions of rhIGF-I closely resemble those of insulin, despite a concomitant inhibitory effect on insulin secretion.

摘要

在9名健康非肥胖受试者中研究了重组人生长激素释放因子I(rhIGF-I)对葡萄糖、氨基酸和游离脂肪酸(FFA)代谢的影响。每位受试者接受了3小时的rhIGF-I首剂持续输注(20微克/千克推注,0.4微克·千克-1·分钟-1),同时通过外源性葡萄糖输注维持血糖正常。总IGF-I水平从125±11 ng/ml增至444±22 ng/ml,游离IGF-I水平从检测不到升至73±5 ng/ml。胰岛素水平从95±9 pM降至64±8 pM,C肽从453±48 pM降至206±29 pM;循环胰高血糖素水平也从72±9 pg/ml降至42±4 pg/ml。rhIGF-I使[3H]葡萄糖测量的葡萄糖摄取增加了两到三倍(从10.3±0.6至27.4±3微摩尔·千克-1·分钟-1),并且,尽管胰岛素分泌减少,但肝葡萄糖生成仍受到60 - 70%的显著抑制。此外,FFA和支链氨基酸分别下降了40 - 60%(从411±58降至165±36微摩尔,从406±23降至219±14微摩尔)。我们的数据表明,rhIGF-I对正常人体内的葡萄糖(肝脏和外周)、脂质和氨基酸代谢有显著影响。尽管rhIGF-I对胰岛素分泌有抑制作用,但其作用范围与胰岛素非常相似。

相似文献

1
Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism.胰岛素样生长因子I对葡萄糖、脂质和氨基酸代谢的多种作用。
Am J Physiol. 1992 Jan;262(1 Pt 1):E130-3. doi: 10.1152/ajpendo.1992.262.1.E130.
2
Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin.胰岛素样生长因子I对清醒禁食大鼠葡萄糖和氨基酸代谢的急性影响。与胰岛素的比较。
J Clin Invest. 1989 May;83(5):1717-23. doi: 10.1172/JCI114072.
3
Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults.重组人胰岛素样生长因子-I与胰岛素代谢效应的比较。健康青年和中年成年人的剂量反应关系。
J Clin Invest. 1994 Mar;93(3):1131-9. doi: 10.1172/JCI117065.
4
A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.低剂量正常血糖输注重组人生长因子I可迅速抑制人体空腹时增强的脉冲式生长激素分泌。
J Clin Invest. 1993 Jun;91(6):2453-62. doi: 10.1172/JCI116480.
5
Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback.衰老对生长激素分泌对胰岛素样生长因子-I负反馈敏感性的影响。
J Clin Endocrinol Metab. 1997 Sep;82(9):2996-3004. doi: 10.1210/jcem.82.9.4223.
6
rhIGF-I administration in humans: differential metabolic effects of bolus vs. continuous subcutaneous delivery.人使用重组胰岛素样生长因子-I(rhIGF-I):推注给药与持续皮下给药的不同代谢效应
Am J Physiol. 1997 Apr;272(4 Pt 1):E628-33. doi: 10.1152/ajpendo.1997.272.4.E628.
7
Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans.低剂量重组人胰岛素样生长因子-I对人体蛋白质合成代谢无影响,但会抑制胰岛细胞分泌。
J Clin Endocrinol Metab. 1992 Nov;75(5):1192-7. doi: 10.1210/jcem.75.5.1430078.
8
Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.重组人胰岛素样生长因子I给药对肥胖症患者生长激素(GH)释放激素刺激生长激素(GH)反应的影响。
J Clin Endocrinol Metab. 2001 Jan;86(1):167-71. doi: 10.1210/jcem.86.1.7110.
9
Insulin-like growth factor I inhibits glucose-stimulated insulin secretion but does not impair glucose metabolism in normal humans.胰岛素样生长因子I抑制正常人葡萄糖刺激的胰岛素分泌,但不损害葡萄糖代谢。
J Clin Endocrinol Metab. 1993 Mar;76(3):804-6. doi: 10.1210/jcem.76.3.8445040.
10
Recombinant human insulin-like growth factor-I abolishes changes in insulin requirements consequent upon growth hormone pulsatility in young adults with type I diabetes mellitus.重组人胰岛素样生长因子-I消除了I型糖尿病年轻成人因生长激素脉冲性导致的胰岛素需求变化。
Metabolism. 1998 Jan;47(1):31-8. doi: 10.1016/s0026-0495(98)90189-5.

引用本文的文献

1
Eye on the horizon: The metabolic landscape of the RPE in aging and disease.关注前沿:衰老和疾病中视网膜色素上皮的代谢图景。
Prog Retin Eye Res. 2025 Jan;104:101306. doi: 10.1016/j.preteyeres.2024.101306. Epub 2024 Oct 19.
2
Platelet-Rich Plasma for Degenerative Spine Disease: A Brief Overview.富血小板血浆治疗退行性脊柱疾病:简要概述
Spine Surg Relat Res. 2023 Jul 6;8(1):10-21. doi: 10.22603/ssrr.2023-0079. eCollection 2024 Jan 27.
3
Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease.
非酒精性脂肪性肝病患者中 IGF-1 和 IGF 结合蛋白与疾病严重程度和血糖的关系。
J Clin Endocrinol Metab. 2021 Jan 23;106(2):e520-e533. doi: 10.1210/clinem/dgaa792.
4
Possible effects of an early diagnosis and treatment in patients with growth hormone deficiency: the state of art.生长激素缺乏症患者早期诊断和治疗的可能影响:现状。
Ital J Pediatr. 2017 Sep 16;43(1):81. doi: 10.1186/s13052-017-0402-8.
5
Insulin-like growth factor-1 is a negative modulator of glucagon secretion.胰岛素样生长因子-1是胰高血糖素分泌的负调节因子。
Oncotarget. 2017 Jun 16;8(31):51719-51732. doi: 10.18632/oncotarget.18514. eCollection 2017 Aug 1.
6
Role of nitric oxide in kidney and liver (as distance organ) function in bilateral renal ischemia-reperfusion: Effect of L-Arginine and NG-nitro-L-Arginine methyl ester.一氧化氮在双侧肾缺血再灌注时肾脏和肝脏(作为远处器官)功能中的作用:L-精氨酸和NG-硝基-L-精氨酸甲酯的影响
Adv Biomed Res. 2015 Oct 22;4:233. doi: 10.4103/2277-9175.167954. eCollection 2015.
7
Effects of intensive glycemic control on serum levels of insulin-like growth factor-I and dehydroepiandrosterone sulfate in Type 2 diabetes mellitus.强化血糖控制对 2 型糖尿病患者血清胰岛素样生长因子-I 和硫酸脱氢表雄酮水平的影响。
J Endocrinol Invest. 2012 May;35(5):469-72. doi: 10.3275/8033. Epub 2011 Oct 10.
8
Analysis of circulating insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) in tobacco smokers and non-smokers.吸烟者与非吸烟者循环胰岛素样生长因子-1(IGF-1)和胰岛素样生长因子结合蛋白-3(IGFBP-3)的分析。
Tob Induc Dis. 2002 Jun 15;1(2):157-70. doi: 10.1186/1617-9625-1-2-157.
9
Nutrition, anabolism, and the wound healing process: an overview.营养、合成代谢与伤口愈合过程:概述
Eplasty. 2009;9:e9. Epub 2009 Feb 3.
10
Plasma insulinlike growth factor 1 and binding-protein 3 and risk of myocardial infarction in women: a prospective study.血浆胰岛素样生长因子1及结合蛋白3与女性心肌梗死风险:一项前瞻性研究
Clin Chem. 2008 Oct;54(10):1682-8. doi: 10.1373/clinchem.2008.105825. Epub 2008 Aug 14.